Summary
Anti-doping authorities at the Tour de France have denied claims of favoritism towards French rider Paul Seixas, who has not yet undergone nocturnal testing unlike rivals Tadej Pogacar and Jonas Vingegaard. Seixas and his team were tested as part of the biological passport program, but accusations of preferential treatment persist.